{"title":"Neurology","description":null,"products":[{"product_id":"pharmacological-treatment-of-epileptic-seizures","title":"Pharmacological Treatment of Epileptic Seizures","description":"\u003cp\u003eby Xuefeng Wang (ed.), Liemin Zhou (ed.) Redirection of the focus of epilepsy treatment from preventing the development of epilepsy to preventing epileptic seizures by the International League Against Epilepsy (ILAE) in 2021 results in major changes in the theory, basic principles and expected purposes of pharmacological therapy of epilepsy. Adapting to the change, this book clarifies the theory, significance, methods, principles and precautions regarding antiepileptic seizures from a new perspective. Divided into nine chapters, this book introduces the new approach toward epileptic seizures, treatment theory, medications, treatment principles, clinical applications, adverse reactions and so on. The treatment of epilepsy comorbidities and methods for terminating status epilepticus, which are rarely covered in previous drug treatment publications, are described in details. It will be a helpful for practitioners in neurology, neurosurgery, emergency care and critical care medicine.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537474138353,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819685202.jpg?v=1786384494"},{"product_id":"drug-discovery-approaches-for-the-treatment-of-neurodegenerative-disorders-2nd-edition","title":"Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders, 2nd Edition","description":"\u003cp\u003eby Adeboye Adejare PhD (ed.) Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease, Second Edition delves into the complexities of drug discovery, specifically for Alzheimer's Disease, presenting the necessary paradigm for future success in research and treatment. This edition is thoroughly updated with recent developments in therapeutic strategies, including amyloid hypothesis, tau, apo E, insulin, and others, and introduces a new chapter on drug delivery to the brain. Additionally, the book encompasses diagnosis, epidemiology, drug discovery strategies, current therapeutics, and more, offering a comprehensive approach to Alzheimer's Disease.It covers the latest in targeted drug design, preclinical studies, and animal models, making it an essential resource for pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers. Patients and advocacy groups can also gain valuable insights from the overview of current treatments and scientific advancements in the field. - Covers Monoclonal Antibodies approaches - Provides a compilation of chemical considerations required in drug discovery for the treatment of neurodegenerative disorders - Explores how in vitro and in vivo models translate to human physiology\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537506119921,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443300080.jpg?v=1786384586"},{"product_id":"immunotherapies-for-neurologic-diseases","title":"Immunotherapies for Neurologic Diseases","description":"\u003cp\u003eby Marinos C. Dalakas Immunotherapies for Neurologic Diseases, Volume 214 explores how neuroimmunotherapies intervene by targeting key molecules and pathways responsible for tissue damage in the central and peripheral nervous systems. The book details approved treatments that modulate T-cell signaling, antigen presentation, B cells and their trophic factors, autoantibodies, Fc receptors, complement, cytokines, and cell adhesion molecules. Each chapter includes clear explanations and illustrations, helping clinicians understand the mechanisms of these drugs in autoimmune neurological diseases. The volume serves as a practical and comprehensive guide, making complex therapeutic approaches accessible to medical professionals and students.The second section highlights the latest therapies for major autoimmune neurological diseases, offering step-by-step algorithms and escalation strategies for selecting optimal treatments. Controversies and uncertainties in therapy choices are discussed by leading experts, while additional chapters address emerging immunotherapeutic approaches for neurodegenerative diseases and the evolving concept of treating autoimmune pain. The book also covers practical applications of traditional immunosuppressants, IVIg, and targeted monoclonal antibodies, with dedicated chapters on conditions such as encephalitis, NMOSD, multiple sclerosis, and stiff person syndrome. - Summarizes and consolidates new research on immunotherapies for neurologic diseases - Identifies how immunotherapies work - Includes monoclonal antibodies or fusion proteins against B cells, T cells, and FcRn - Provides treatment algorithms and escalating therapies for common diseases - Highlights new agents in pipeline orin early trials\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537509953777,"sku":null,"price":49.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780323908870.jpg?v=1786384597"},{"product_id":"neurodegeneration","title":"Neurodegeneration","description":"\u003cp\u003eby Vivek P. Chavda (ed.), Rajashri Bezbaruah (ed.), Bibhuti Bhushan Kakoti (ed.), Vladimir N. Uversky (ed.) Neurodegeneration, the progressive loss of structure and function of neurons in the body, is a condition that affects millions of people globally. This new book covers the basics of neurodegeneration as well as the etiology, epidemiology, and diagnostics of neurodegenerative illnesses in depth. A thorough discussion of the molecular mechanisms behind neurodegenerative illnesses is provided, with particular emphasis on the roles that protein folding and misfolding play in the onset and progression of these conditions. Recent advancements in neurodegeneration associated with brain iron buildup, oxidative stress, and biomarker research are also covered. Repurposed medications, approved treatment approaches for neurodegenerative illnesses, and the application of AI and machine learning for diagnosis and therapy are all discussed. Along with cutting-edge CRISPR\/Cas and genetic techniques, the book also emphasizes the potential of ethnomedicinal contributions toward neurodegenerative illnesses.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537512575217,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781998511822.jpg?v=1786384605"},{"product_id":"pocket-guide-neuro-psychopharmaka-im-kindes-und-jugendalter-3rd-edition","title":"Pocket Guide Neuro-\/Psychopharmaka im Kindes- und Jugendalter, 3rd Edition","description":"\u003cp\u003eby Manfred Gerlach, Andreas Warnke Dieser praktische Pocket Guide bietet auf einen Blick die wichtigsten Informationen zur medikamentösen Therapie mit Neuro-\/Psychopharmaka im Kindes- und Jugendalter. Er besticht durch die komprimierte und einheitliche Darstellung mit vielen Tabellen. Mit der Sortierung von A bis Z finden Sie schnell und übersichtlich die \"Erste-Hilfe\"-Information rund um alle relevanten Wirkstoffe, die Sie auf Station und im Praxisalltag brauchen.​ Das Buch dient dabei auch als Entscheidungshilfe zur Wahl der Medikation und gibt handlungsleitende Antworten zu den wichtigsten Fragen der medikamentösen Behandlung: Welche psychopharmakologische Substanz steht zur Verfügung? Ist sie für die zu behandelnde Person und Symptomatik indiziert und zugelassen? Welche Dosierung ist verfügbar und zu wählen? Wie rasch und wie anhaltend ist die Wirkung? Welche unerwünschten Arzneimittelwirkungen (UAWs) sind zu beachten? Die Neuauflage wurde aktualisiert und mit neuen Wirkstoffen ergänzt. Sie wendet sich an Kinder- und Jugendpsychiater und -psychotherapeuten, Psychiater, Pädiater, Allgemeinmediziner, Psychologen, Pflegekräfte und Lehrer.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537519128817,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783662720684.jpg?v=1786384624"},{"product_id":"frontiers-in-clinical-drug-research-cns-and-neurological-disorders-volume-9","title":"Frontiers in Clinical Drug Research – CNS and Neurological Disorders: Volume 9","description":"\u003cp\u003eBy Atta -ur-Rahman, Zareen Amtul Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology. The ninth volume of this series features reviews that cover the following topics related to the treatment of a different CNS disorders, related diseases and basic neuropharmacology research: - Integrating imaging and microdialysis into systems neuropharmacology- Depression heterogeneity and the potential of a transdiagnostic and dimensional approach to identify biologically relevant phenotypes- CAR-T cells in brain tumors and autoimmune diseases – from basics to the clinic- Revaluation of thyrotropin-releasing hormone and its mimetics as candidates for treating a wide range of neurological and psychiatric disorders- Natural BACE1 inhibitors: promising drugs for the management of Alzheimer’s disease- The possibilities of safe lithium therapy in the treatment of neurological and psychoemotional disorders- Pharmacotherapy of multiple sclerosis and treatment strategies Product Details Publisher ‏ : ‎ Bentham Science Publishers Publication date ‏ : ‎ October 15, 2021 Language ‏ : ‎ English ISBN-10 ‏ : ‎ 1681089068 ISBN-13 ‏ : ‎ 978-1681089065\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537543213297,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-1681089065-1.webp?v=1786384714"},{"product_id":"advances-in-alcohol-use-disorder-treatment-volume-178-international-review-of-neurobiology-volume-178","title":"Advances in Alcohol Use Disorder Treatment (Volume 178) (International Review of Neurobiology, Volume 178)","description":"\u003cp\u003eBy Rosana Camarini, Fabio Cardoso Cruz Advances in Alcohol Use Disorder Treatment, Volume 178 in the International Review in Neurobiology series, presents a comprehensive exploration of emerging therapies and approaches in the field. Topics in this new release include Introduction: Current Treatments, Oxytocin and Vasopressin, Neuroactive steroids, Pharmacological activators of ALDH2, Anti inflammatories and mesenchymal stem cells, Sodium oxybate, Psychedelic compounds, Cannabinoids, Environmental Enrichment, Animal models and translational challenges, GABAergic compounds, and Ghrelin system and GLP-1. Explores neurobiological, pharmacological, and unconventional modalities for treating AUD Integrates insights from leading experts, bridging pre-clinical and clinical viewpoints Investigates new compounds and cutting-edge research in AUD treatment Product Details Publisher ‏ : ‎ Academic Press; 1st edition (November 27, 2024) Language ‏ : ‎ English Hardcover ‏ : ‎ 454 pages ISBN-10 ‏ : ‎ 0443296383 ISBN-13 ‏ : ‎ 978-0443296383\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537546260721,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-0443296383-9780443296390-1.webp?v=1786384738"},{"product_id":"horizons-in-neuroscience-research-volume-51","title":"Horizons in Neuroscience Research. Volume 51","description":"\u003cp\u003eBy Eugenio Villalba Andres Costa This volume consists of twelve chapters that detail the latest neuroscience research. Chapter one examines shunt fluid as a diagnostic procedure to evaluate ventriculoperitoneal shunt malfunction and infection. Chapter two investigates the effects of lycopene on neurodegenerative diseases. The purpose of chapter three is to diagnose the state of small vesicles in the paralyzed arm of the probant and try to find a way to activate them. The objective of chapter four is to compare the density and distribution of the ‘signature’ pathological lesions in the hippocampus and adjacent PHG in fourteen neurodegenerative disorders using a standardized quantitative protocol. Chapter five investigates the effects of electrical stimulation (ES) applied to the lateral cerebellar nucleus (LCN) in rats with early and fully developed pentylenetetrazol (PTZ)-kindled seizures. Chapter six provides a review on Down’s Syndrome. Chapter seven summarizes current knowledge on P2X receptor activation. Chapter eight highlights the need for balanced, ethical, and patient-centered approaches in the evolving landscape of ADHD treatment. Chapter nine hones in on historical discoveries derived and expanded from the Xenopus frogs and tadpoles as a model organism. Product Details ASIN ‏ : ‎ B0D2PBRBJN Publisher ‏ : ‎ Nova Science Publishers, Inc. (June 19, 2024) Language ‏ : ‎ English Hardcover ‏ : ‎ 209 pages ISBN-13 ‏ : ‎ 979-8891137110\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537549144305,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/8891137110-1.webp?v=1786384765"},{"product_id":"neuropsychology-and-substance-use-disorders-assessment-and-treatment","title":"Neuropsychology and Substance Use Disorders: Assessment and Treatment","description":"\u003cp\u003eBy Richard Alecsander Reichert, Andre Luiz Monezi Andrade, Denise De Micheli This book is a comprehensive guide for health professionals working with psychoactive drug use and dependence who want to learn the nuts and bolts of the neuropsychology of substance use disorders. It presents the basic foundations of neuropsychology, including a historical overview of studies and research, theoretical and conceptual bases, and practical applications to the area of psychoactive drug use and dependence. It also includes a comprehensive introduction to the history, theoretical models, diagnostic criteria and epidemiology of substance use disorders. With a special focus on practice and applied knowledge, the volume presents the main methods of neuropsychological assessment of substance use disorders and reviews the most important neuropsychological and psychotherapeutic interventions to treat substance use disorders. Additionally, whole sections of the book are dedicated to explaining the impacts of substance use on cognitive and executive functions and the relationship between substance use and mental disorders in adolescence. Finally, the book also includes brief introductions to the neurobiology of substance use disorders and to research methodologies for studying the neuroscience of psychoactive substance use. Neuropsychology and Substance Use Disorders: Assessment and Treatment will be an invaluable resource for health and care professionals from different areas, such as clinical psychology, psychiatry, nursing and social woacrk, who are looking for a friendly introduction to the neuropsychology of substance use disorders. It will also be a helpful tool for graduate and undergraduate psychology students interested in specializing in this field of knowledge and practice. Product Details Publisher ‏ : ‎ Springer (March 15, 2025) Language ‏ : ‎ English Hardcover ‏ : ‎ 713 pages ISBN-10 ‏ : ‎ 3031826132 ISBN-13 ‏ : ‎ 978-3031826139\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537549406449,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-3031826139-9783031826146-1.webp?v=1786384772"},{"product_id":"the-brain-and-pain-breakthroughs-in-neuroscience","title":"The Brain and Pain: Breakthroughs in Neuroscience","description":"\u003cp\u003eBy Richard Ambron Pain is an inevitable part of existence, but severe debilitating or chronic pain is a pathological condition that diminishes the quality of life. The Brain and Pain explores the present and future of pain management, providing a comprehensive understanding based on the latest discoveries from many branches of neuroscience.Richard Ambron―the former director of a neuroscience lab that conducted leading research in this field―explains the science of how and why we feel pain. He describes how the nervous system and brain process information that leads to the experience of pain, detailing the cellular and molecular functions that are responsible for the initial perceptions of an injury. He discusses how pharmacological agents such as opiates affect the duration and intensity of pain. Ambron examines new evidence showing that discrete circuits in the brain modulate the experience of pain in response to a placebo, fear, anxiety, belief, or other circumstances, as well as how pain can be relieved by activating these circuits using mindfulness training and other nonpharmacological treatments. The book also evaluates the prospects of procedures such as deep brain stimulation and optogenetics.Current and thorough, The Brain and Pain will be invaluable for a range of people seeking to understand their options for treatment as well as students in neuroscience and medicine. Product Details Publisher ‏ : ‎ Columbia University Press (March 1, 2022) Language ‏ : ‎ English Paperback ‏ : ‎ 264 pages ISBN-10 ‏ : ‎ 0231204876 ISBN-13 ‏ : ‎ 978-0231204873\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537552683249,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-0231204873-9780231555715-9780231204866.webp?v=1786384829"},{"product_id":"interaction-of-nervous-and-endocrine-mechanisms-in-integrative-brain-activity-and-behaviour","title":"Interaction of Nervous and Endocrine Mechanisms in Integrative Brain Activity and Behaviour","description":"\u003cp\u003eBy Liudmila A. Severyanova, Dmitry V. Plotnikov, Ksenia D. Plotnikova The material in this monograph was obtained by the authors in years of research carried out at Kursk State Medical University, Russia. This original, evidence-based research studied the behavior and effects of peptide hormones (melanocortins) and corticosteroids on the excitability and interaction of brain structures. Multiple objective indicators of brain functioning were recorded, taking into account behavioral, motor and visceral manifestations; stereotactic technique, electroencephalography, electrocardiography, electromyography, neuropharmacological and structural-functional analysis were used. The mechanisms of hormonal influence on integrative brain activity that ensure the selection and maintenance of biologically adequate behavior and adaptation have been established. Due to the findings of this research, this book explores the origin of mental disorders in diseases of the pituitary and adrenal glands and during hormonal therapy, and to substantiate the purposeful synthesis of active oligopeptides as new drugs. The book will be of use to physiologists, pathophysiologists, endocrinologists, neuropathologists, psychiatrists, university students, and doctors taking upgrading courses. Product Details Publisher ‏ : ‎ Cambridge Scholars Publishing (July 2, 2024) Language ‏ : ‎ English Hardcover ‏ : ‎ 207 pages ISBN-10 ‏ : ‎ 1036406687 ISBN-13 ‏ : ‎ 978-1036406684\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537554092273,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-1036406684.webp?v=1786384847"},{"product_id":"biomaterials-and-neurodegenerative-disorders","title":"Biomaterials and Neurodegenerative Disorders","description":"\u003cp\u003eBy Gaurav Kumar, Sumedha Mukherjee, Santosh Kumar The book covers the fundamental aspects of biomaterials, including their introduction, types, synthesis, and characterization. It delves into the field of neuro-compatible biomaterials, examining nervous tissue response and the role of biomaterials in neuroprotection. It discusses clinical trials and applications along with intellectual property rights in neuroprotective biomaterials. The book also explores the innovative neuro-targeted drug delivery system and its potential in improving treatment outcomes. Lastly, it explores biomaterials' impact on neurodegeneration and neuro diagnosis, providing valuable insights for researchers, academicians and doctoral students working in the field of Neuroscience, Neuroprotection, Biomaterial based Neurotherapeutics, Biomaterial based Neuro diagnosis and Biomaterial mediated drug delivery. Product Details Publisher ‏ : ‎ Springer; 2025th edition (January 23, 2025) Language ‏ : ‎ English Hardcover ‏ : ‎ 289 pages ISBN-10 ‏ : ‎ 9819799589 ISBN-13 ‏ : ‎ 978-9819799589\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537555206385,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-9819799589-9789819799596-1.jpg?v=1786384871"},{"product_id":"therapie-und-verlauf-neurologischer-erkrankungen-german-edition","title":"Therapie Und Verlauf Neurologischer Erkrankungen (German Edition)","description":"\u003cp\u003eBy Hans Christoph Diener, Christian Gerloff, Marianne Dieterich, Matthias Endres Das grosse Referenz- und Facharztbuch zur klinischen Neurologie liegt jetzt unter der Federfuhrung des international renommierten Herausgeberteams und der Mitarbeit von uber 150 FachexpertInnen als eine erweiterte und komplett uberarbeitete Neuauflage vor. In bewahrter Form werden systematisch die aktuellen Erkenntnisse zum Stand von Klinik, Verlauf und Therapie neurologischer Erkrankungen zusammengefasst und fur die praktische Anwendung gewichtet - nicht nur fur haufige Krankheiten wie Schlaganfall, Epilepsie, Multiple Sklerose und M. Parkinson, sondern auch fur seltene Krankheitsbilder. Neue Kapitel zu funktionellen Bewegungsstorungen, dissoziativen Anfallen, spinaler Muskelatrophie oder auch zu neurologischen Nebenwirkungen von Tumor-Therapien machen die 8. Auflage zusatzlich attraktiv. Das Werk wurde konzeptionell und didaktisch weiterentwickelt, um den Anforderungen des modernen und immer starker digital gepragten Klinikalltags gerecht zu werden: Fur eine rasche Orientierung beginnen alle Kapitel mit einem Uberblick uber die wichtigsten Inhalte und Textboxen markieren besonders relevante Informationen. Die Bewertungen von Evidenzlevels und Empfehlungsstarken der relevanten Therapien sowie klinische Pfade veranschaulichen die Best Practice. Das etablierte Werk - begrundet von den Herausgebern Brandt\/Dichgans\/Diener - knupft an den Erfolg der Vorauflagen an und ist fur die alltagliche Arbeit von FacharztInnen und AllgemeinmedizinerInnen in Klinik und Praxis sowie fur eine erfolgreiche Aus-, Fort- und Weiterbildung nicht wegzudenken. Product Details Publisher ‏ : ‎ Kohlhammer (October 31, 2023) Language ‏ : ‎ German Hardcover ‏ : ‎ 1704 pages ISBN-10 ‏ : ‎ 3170399667 ISBN-13 ‏ : ‎ 978-3170399662\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537556844785,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-3170399662.webp?v=1786384898"},{"product_id":"cannabidiol-in-neurology-and-psychiatry-volume-177-international-review-of-neurobiology-volume-177","title":"Cannabidiol in Neurology and Psychiatry (Volume 177) (International Review of Neurobiology, Volume 177)","description":"\u003cp\u003eBy Elaine Del-Bel, Sabrina Francisca de Souza Lisbôa, Felipe V. Gomes Cannabidiol in Neurology and Psychiatry, Volume 177 in the International Review in Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on topic such as Historical perspective on the therapeutic potential of cannabidiol, Cannabidiol: pharmacodynamics pharmacokinetic, Cannabidiol and Alzheimer’s disease, Cannabidiol on anxiety disorders, Cannabidiol on psychosis, Cannabidiol on autism spectrum disorders, Cannabidiol in Epilepsy, Cannabidiol in Ischemia\/stroke, Cannabidiol in Depression, Cannabidiol and Abuse of drugs, and much more.Additional chapters cover Cannabidiol in fear response and PTSD, Cannabidiol and Pain. and Cannabidiol and Parkinson’s disease. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in the International Review on Neurobiology series Updated release includes the latest information on Cannabidiol in Neurology and Psychiatry Product Details Publisher ‏ : ‎ Academic Press; 1st edition (July 31, 2024) Language ‏ : ‎ English Hardcover ‏ : ‎ 350 pages ISBN-10 ‏ : ‎ 0443235910 ISBN-13 ‏ : ‎ 978-0443235917\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537556943089,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-0443235917-9780443235924-1.webp?v=1786384902"},{"product_id":"a-review-on-diverse-neurological-disorders-pathophysiology-molecular-mechanisms-and-therapeutics","title":"A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics","description":"\u003cp\u003eBy Rameshwar Nath Chaurasia, Sunny Ohia PhD  FARVO  FAS, Debasis Bagchi PhD A Review of Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics offers an unparalleled compilation of the current understanding of neurodegenerative disorders. This book investigates the origins of mental disorders, encompassing bacterial and fungal invasions, viral assaults, and genetic predispositions, providing readers with a thorough grasp of the neurological landscape. Each chapter dissects the intricacies of these incapacitating conditions, ranging from the pathogenesis of central nervous system tuberculosis to the involvement of endocannabinoids in rabies infection. Topics such as neuroinflammation, axonal pathology, and the intricate relationship between diet, gut microbiomes, and cognitive decline are also explored. This book conducts an extensive examination of neurodegeneration, incorporating discussions on the role of probiotics and natural bioactive compounds in preventing ailments such as Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). With meticulous analyses of vitamins, micronutrients, antioxidants, and nutraceuticals, this work offers a roadmap for promoting neuroprotection. A Review of Diverse Neurological Disorders serves as a resource that not only reviews the current understanding but also lays the groundwork for future treatments and innovations. Epidemiology of neurological disorders and pathogenesis. Explores neuroinflammation, ligand-receptors binding, and neurodegeneration. Discusses aging and associated disorders in the onset of neurological disorders. Neuropharmacology and the protective role of bioactive compounds in neuroprotection. Product Details Publisher ‏ : ‎ Academic Press; 1st edition (July 3, 2024) Language ‏ : ‎ English Paperback ‏ : ‎ 730 pages ISBN-10 ‏ : ‎ 0323957358 ISBN-13 ‏ : ‎ 978-0323957359\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537560318193,"sku":null,"price":140.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-0323957359-9780323957366.jpg?v=1786384921"},{"product_id":"praktische-neurogeriatrie-syndrome-und-krankheitsbilder-diagnostik-und-therapie-sozialmedizin-und-recht-2nd-edition","title":"Praktische Neurogeriatrie: Syndrome Und Krankheitsbilder – Diagnostik Und Therapie – Sozialmedizin Und Recht, 2nd Edition","description":"\u003cp\u003eBy Thomas Gunnewig, Frank Erbguth, Kai Boelmans The growing proportion of neurological diseases in the elderly means that physicians need to have specific knowledge of the topic in everyday clinical work. This book gathers together empirical knowledge and clinical experience in the field of neurogeriatrics into a practical textbook. Renowned authors from the fields of neurology and geriatrics, neurosurgery, pharmacology, psychiatry, psychology, rehabilitation medicine and urology provide an interdisciplinary focus on neurological aspects of age multimorbidity. This second, enlarged and updated edition has been restructured and expanded to include the neurogeriatric syndromes of immobility, instability, intellectual decline, isolation in old age, incontinence and iatrogenic disorders. Special aspects of pharmacotherapy in the elderly are now given considerably more space and attention. The specific clinical pictures and practical aspects relevant to action in the fields of ethics, law and social medicine have been updated. Information panels and checklists provide quick overviews. Product Details Publisher ‏ : ‎ Kohlhammer; 2nd 2., Erweiterte Und Aktualisierte Auflage ed. (January 12, 2022) Language ‏ : ‎ German Hardcover ‏ : ‎ 785 pages ISBN-10 ‏ : ‎ 3170355457 ISBN-13 ‏ : ‎ 978-3170355453\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537563726065,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-3170355453.webp?v=1786384936"},{"product_id":"approaches-for-brain-targeting-using-nanoparticulate-systems-255th-edition","title":"Approaches for Brain Targeting Using Nanoparticulate Systems, 255th Edition","description":"\u003cp\u003eby Bhagyashree V. Salvi PhD, Pravin Shende PhD, Fabrizio Caldera Approaches for Brain Targeting Using Nanoparticulate Systems aims to explore variety of nanoparticulate systems in the enhancement of therapeutic delivery, promotion for effective brain targeting, and reduction in the off-targets. Presenting the latest research, this book offers comprehensive insight into various nanosystems designed to overcome the blood brain barrier. This book presents the latest research on targeting approaches, physicochemical characteristics of nanoparticles, and the role of nanoparticles in enhancing the permeation of therapeutic systems across the blood brain barrier. Readers will also be able to develop a deeper understanding of how nanotherapeutics can revolutionize brain targeting through clinical applications.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537573949681,"sku":null,"price":49.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443364532.jpg?v=1786385006"},{"product_id":"rodent-models-of-neurodegenerative-disease-neuroscience-of-neurodegenerative-disease","title":"Rodent Models of Neurodegenerative Disease (Neuroscience of Neurodegenerative Disease)","description":"\u003cp\u003eby Pegah Javadpour (ed.), Rasoul Ghasemi (ed.) Rodent Models of Neurodegenerative Disease explores neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal dementia, Lewy body disease, and prion disease which represent some of the most complex and devastating challenges in neuroscience. With rising prevalence in aging populations worldwide, these disorders place immense burdens on patients, families, and healthcare systems. This comprehensive volume, Rodent Models of Neurodegenerative Disease, provides an in-depth examination of the utility, strengths, and limitations of rodent models in unraveling the molecular, cellular, and behavioral aspects of neurodegeneration. Organized by disease, each chapter explores both genetic and non-genetic models, highlighting their relevance to human pathology, translational value, and contributions to therapeutic discovery. Key features of this book include the following: Detailed coverage of rodent models for major neurodegenerative diseases Critical analysis of disease mechanisms, from protein aggregation and mitochondrial dysfunction to neuroinflammation and synaptic loss A dedicated chapter on behavioral assays, bridging molecular pathology with motor, cognitive and social outcomes Insights into the translational challenges of preclinical research and its role in shaping future therapies With contributions from leading neuroscientists, this book serves as a valuable reference for researchers, graduate students, and professionals in neuroscience, neurology, pharmacology, and related fields. Whether for experimental design, model selection, or therapeutic evaluation, it provides an essential guide for advancing neurodegenerative disease research.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537574244593,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040515365-1.jpg?v=1786385014"}],"url":"https:\/\/pharmalibrary.online\/collections\/neurology.oembed","provider":"Pharma","version":"1.0","type":"link"}